Beneficial effects of muscone on cardiac remodeling in a mouse model of myocardial infarction
Open Access
- 2 May 2014
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 34 (1), 103-111
- https://doi.org/10.3892/ijmm.2014.1766
Abstract
Musk has been traditionally used in East Asia to alleviate the symptoms of angina pectoris. However, it remains unclear as to whether muscone, the main active ingredient of musk, has any beneficial effects on persistent myocardial ischemia in vivo. The aim of the present study was to investigate whether muscone can improve cardiac function and attenuate myocardial remodeling following myocardial infarction (MI) in mice. Mice were subjected to permanent ligation of the left anterior descending coronary artery to induce MI, and then randomly treated with muscone (2 mg/kg/day) or the vehicle (normal saline) for 3 weeks. Sham-operated mice were used as controls and were also administered the vehicle (normal saline). Treatment with muscone significantly improved cardiac function and exercise tolerance, as evidenced by the decrease in the left ventricular end-systolic diameter, left ventricular end-diastolic diameter, as well as an increase in the left ventricular ejection fraction, left ventricular fractional shortening and time to exhaustion during swimming. Pathological and morphological assessments indicated that treatment with muscone alleviated myocardial fibrosis, collagen deposition and improved the heart weight/body weight ratio. Muscone inhibited the inflammatory response by reducing the expression of transforming growth factor (TGF)‑β1, tumor necrosis factor (TNF)-α, interleukin (IL)-1β and nuclear factor (NF)-κB. Treatment with muscone also reduced myocardial apoptosis by enhancing Bcl-2 and suppressing Bax expression. Muscone also induced the phosphorylation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS). Our results demonstrate that muscone ameliorates cardiac remodeling and dysfunction induced by MI by exerting anti-fibrotic, anti-inflammatory and anti-apoptotic effects in the ischemic myocardium.Keywords
This publication has 44 references indexed in Scilit:
- Chemical Fingerprinting of Shexiang Baoxin Pill and Simultaneous Determination of Its Major Constituents by HPLC with Evaporative Light Scattering Detection and Electrospray Mass Spectrometric DetectionCHEMICAL & PHARMACEUTICAL BULLETIN, 2006
- Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial IschemiaCirculation Research, 2005
- [Effect of shexiang baoxin pill in alleviating myocardial fibrosis in spontaneous hypertensive rats].2005
- Fibrosis as a Therapeutic Target Post-Myocardial InfarctionCurrent Pharmaceutical Design, 2005
- The Mitochondrial Death Pathway and Cardiac Myocyte ApoptosisCirculation Research, 2004
- Characterization of Allegedly Musk-Containing Medicinal Products in TaiwanJournal of Forensic Sciences, 2004
- Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in MiceCell Metabolism, 1999
- Regulation of endothelium-derived nitric oxide production by the protein kinase AktNature, 1999
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis.The Journal of cell biology, 1996